Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Human Prochymase Activation
M. Murakami, S. S. Karnik, A. Husain
Published 1995 · Chemistry, Medicine, Biology
Save to my Library
Download PDFAnalyze on Scholarcy
Human prochymase is packaged with heparin in mast cell granules and appears to be activated by dipeptidylpeptidase I. We show that a high affinity interaction between heparin and prochymase allows the 2-residue propeptide to be cleaved by dipeptidylpeptidase I. A conserved Glu in the propeptide is necessary for this heparin effect. Following propeptide cleavage, capture of the newly generated NH2 terminus by an “activation groove” on the enzyme activates the enzyme and concurrently prevents a progressive degradation of the NH2 terminus by dipeptidylpeptidase I. Surrogate peptide studies show that the activation groove is unoccupied in prochymase and is specific for the chymase NH2 terminus. These observations indicate that heparin is an important cofactor in the prochymase activation process and explain how dipeptidylpeptidase I, a nonspecific processing enzyme, can effect a specific cleavage of the zymogen propeptide.
This paper references
Cell Biology of Extracellular Matrix
E. Hay (1991)
Measurement of the internal pH of mast cell granules using microvolumetric fluorescence and isotopic techniques.
M. B. De Young (1987)
Synthesis of peptides related to the prosegment of mouse submaxillary gland renin precursor: an approach to renin inhibitors.
G. Evin (1984)
Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
H. Urata (1993)
Angiotensin I conversion by human and rat chymotryptic proteinases.
B. Wintroub (1984)
Dog mast cell chymase: molecular cloning and characterization.
G. Caughey (1990)
Substance P regulates the vasodilator activity of calcitonin gene-related peptide
S. Brain (1988)
Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.
H. Urata (1990)
Characterization of rat mast cell granule proteins.
D. Lagunoff (1976)
Detection and partial characterization of a human mast cell carboxypeptidase.
Sanford M. Goldstein (1987)
Site-directed mutagenesis of virtually any plasmid by eliminating a unique site.
W. Deng (1992)
Dipeptide processing activates recombinant human prochymase.
H. Urata (1993)
Mechanisms of zymogen activation.
R. Stroud (1977)
Processing of procarboxypeptidase A and other zymogens in murine mast cells.
M. Dikov (1994)
Identification and molecular cloning of a novel mouse mucosal mast cell serine protease.
W. Serafin (1990)
Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
G. Caughey (1988)
Mast cell chymase. A potent secretagogue for airway gland serous cells.
C. Sommerhoff (1989)
Purification and characterization of dipeptidyl peptidase I from human spleen.
M. J. Mcguire (1992)
Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases.
G. Salvesen (1987)
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.
M. Kozak (1984)
Identification of a novel class of elastase isozyme, human pancreatic elastase III, by cDNA and genomic gene cloning.
T. Tani (1988)
Isolation and complete structure of the lymphocyte serine protease granzyme G, a novel member of the granzyme multigene family in murine cytolytic T lymphocytes. Evolutionary origin of lymphocyte proteases.
D. Jenne (1989)
Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells.
H. Le Trong (1987)
Cloning of the gene and cDNA for human heart chymase.
H. Urata (1991)
On the size of the active site in proteases. I. Papain.
I. Schechter (1967)
Primary structure of human pancreatic elastase 2 determined by sequence analysis of the cloned mRNA.
T. S. Fletcher (1987)
DNA sequencing with chain-terminating inhibitors.
F. Sanger (1977)
An unusual specificity in the activation of neutrophil serine proteinase zymogens.
G. Salvesen (1990)
Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and a multi-gene family.
P. Benfey (1987)
Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes.
A. Sali (1993)
The structure of rat mast cell protease II at 1.9-A resolution.
S. Remington (1984)
Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I.
M. McGuire (1993)
Tryptase from human pulmonary mast cells. Purification and characterization.
L. Schwartz (1981)
This paper is referenced by
Chymase inhibitor-sensitive synthesis of endothelin-1 (1-31) by recombinant mouse mast cell protease 4 and human chymase.
W. Semaan (2015)
New developments in the genetics and activation of mast cell proteases.
G. Caughey (2002)
Biological Function of Mast Cell Chymase In vitro and in vivo studies: a thorny pathway
E. Chugunova (2004)
A novel vascular smooth muscle chymase is upregulated in hypertensive rats.
C. Guo (2001)
Antiproteases as therapeutics to target inflammation in cystic fibrosis.
D. Quinn (2010)
Biological functions and regulation of serglycin-dependent mast cell proteases
A. Lundequist (2006)
The 2.2-Å Crystal Structure of Human Pro-granzyme K Reveals a Rigid Zymogen with Unusual Features*
C. Hink-Schauer (2002)
Human Dipeptidyl-peptidase I
N. Rao (1997)
Identification of an alternative splicing variant of cathepsin C/dipeptidyl-peptidase I.
K. Matsui (2002)
Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?
S. Heuston (2012)
Role of Chymase-Dependent Angiotensin II Formation in Monocrotaline-Induced Pulmonary Hypertensive Rats
K. Kishi (2006)
Altered Storage of Proteases in Mast Cells from Mice Lacking Heparin: A Possible Role for Heparin Carboxypeptidase A Processing
F. Henningsson (2002)
Chapter 18 – Structure and Function of Human Chymase
N. Schechter (2000)
Free‐thiol Cys331 exposed during activation process is critical for native tetramer structure of cathepsin C (dipeptidyl peptidase I)
M. Horn (2002)
Secretory production of recombinant human chymase as an active form in Pichia pastoris
H. Nakakubo (2000)
Serum tryptase and the laboratory diagnosis of systemic mastocytosis.
L. Schwartz (2000)
Characterization of recombinant human chymase expressed in Escherichia coli.
S. Takai (2000)
Functional reconstitution of an active recombinant human chymase from Pichia pastoris cell lysate
H. Nakakubo (2000)
Recombinant Expression of Human Mast Cell Proteases Chymase and Tryptase
Z. Wang (1998)
A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.
K. Sakai (1996)
Activation of recombinant proenteropeptidase by duodenase
T. S. Zamolodchikova (2000)
Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways.
P. Wolters (2000)
Inhibition of dipeptidyl peptidase I in the human mast cell line HMC-1: blocked activation of tryptase, but not of the predominant chymotryptic activity.
P. D. Sheth (2003)
Active monomers of human β-tryptase have expanded substrate specificities
Y. Fukuoka (2007)
Selective Reporter Expression in Mast Cells Using a Chymase Promoter*
Y. Liao (1997)
Regulation and Function of Mast Cell Proteases in Inflammation
C. Huang (2004)
ting neu of trophil
U. Gullberg (1997)
The N-terminal tetrapeptide of neutrophil proteinase 3 causes S-phase arrest in granulopoietic progenitors.
S. Sköld (2005)
The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
P. J. Pereira (1999)
Cloning and characterization of the cDNA encoding mouse dipeptidyl peptidase I (cathepsin C).
M. McGuire (1997)
Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis.
S. Sköld (2002)
Importance of lysosomal cysteine proteases in lung disease
P. Wolters (2000)See more